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Transient left ventricular dysfunction syndrome (TLVDS), or Tako-Tsubo cardiomyopathy (TC), is a clinical entity in which
patients present with features of acute coronary syndrome, electrocardiogram abnormalities, and transient left ventricular (apical
or mid-ventricular) dysfunction. Patients usually recover from this condition four to six weeks after the event. The etiology or
triggering factors of TC remains unknown. Various triggering factors have been associated with this syndrome, with one of the
mostrecentbeingmalignancies.Inthiscasereportwepresentapostmenopausalfemalewithunderlyingadvancedmalignancywho
presented with TC. This is consistent with a recent hypothesis that in addition to currently known triggering factors, malignancies
might well trigger TC in the context of a stressor or paraneoplastic phenomenon.
1.Introduction
Tako-Tsubo cardiomyopathy (TC) is a clinical entity ﬁrst
described in 1991 by Dote et al. [1]. It was initially described
as tako-tsubo, a word derived from the Japanese octopus
trap, which has a similar appearance as the left ventricle
during this event. Other names include stress-induced
cardiomyopathy, apical ballooning syndrome, ampulla car-
diomyopathy,orBrokenHeartsyndrome.Itwasﬁrstthought
to be restricted to the apex of the left ventricle, hence the
name “apical”; however, we now have evidence that other
parts of the left ventricle, as well as the right ventricle, are
involved [2, 3]. Therefore, TC remains the most appropriate
name although the most current literature still refers to it as
a “left ventricular” or “apical” syndrome.
There continues to be a constant evolution in our
understanding of this unique condition as far as etiology,
pathophysiology, and triggering factors are concerned. There
are no large randomized or cohort studies available. Most
of the information known comes from case reports and case
series. Current incidence is unknown; however, some studies
estimate1%to2%ofallpatientspresentwithacutecoronary
syndrome, which puts the incidence at 7,000 to 14,000
cases per year. The condition is common in postmenopausal
women, with a mean age of 58 to 75 years, and <3% under
age 50 [4].
Triggering factors and their mechanisms continue to
generate deep clinical interest. Recent retrospective studies
[5, 6] have unearthed a possible link between malignancies
and TC leading to the hypothesis mentioned above. It is in
support of this hypothesis that we present this case.
2. Case Presentation
A 66-year-old woman with hyperlipidemia and hypertension
presented with acute onset of chest pressure. She denied any
shortness of breath, diaphoresis, palpitations, presyncopal,
or syncopal symptoms. She had no cardiac or diabetic
history. She did not have regular medical care.
Clinically she was in mild distress with tachycardia
at 120bpm. Other vital signs were within normal limits.
Physical examination was normal except for positive
stool Guaiac test. Laboratory values were troponin I
6.5ng/mL, creatinine kinase (isoenzyme—MB) 28.4ng/mL,
white blood cell count (WBC) 19600/uL with 0% bands,
hemoglobin 10.9g/dL, hematocrit 32.7%, normal platelets,2 Case Reports in Medicine
alanine transaminase 36U/L, aspartate transaminase 44U/L,
total alkaline phosphatase 234U/L, sodium 133mmol/L,
and potassium 3.3mmol/L.
Electrocardiogram (ECG) showed ST segment elevation
in precordial leads V2-V3 (Figure 1). Chest X-ray was
normal. Echocardiography showed apical and anterior wall
akinesis (Figure 2). Coronary angiogram revealed normal
coronary vasculature. Left ventriculogram showed ejection
fraction 36% and anteroapical akinesia with an anteroapical
ballooning (Figure 3) .Ac o m p r e h e n s i v ev i r a ls c r e e nt or u l e
out viral myocarditis as an underlying cause of elevated
myocardial enzymes was negative. The patient was managed
per acute coronary syndrome protocol and was discharged
after two days on carvedilol, lisinopril, and aspirin. The
patient denied any psychosocial stressful event prior to
presentation.
Because of her positive Guaiac test and mild anemia,
she was advised to return in four weeks for a diagnos-
tic colonoscopy. Colonoscopy revealed a colorectal mass
with colonic obstruction. Histopathology was consistent
with a poorly diﬀerentiated adenocarcinoma. Computed
tomography (CT) of the abdomen and pelvis revealed stage
IV adenocarcinoma for which an exploratory laparotomy
with diverting sigmoid colostomy and mucous ﬁstula was
performed. This was followed by adjuvant chemotherapy
with FOLFOX (folinic acid, ﬂuorouracil, and oxaliplatin)
regime. She is currently having a sixth cycle.
Repeat echocardiography at four weeks postcardiac event
showed improved ejection fraction (60%) and resolution of
the anteroapical akinesia. Final diagnosis was TC possibly
triggered by underlying advanced malignancy.
3. Discussion
The pathophysiology of TC remains largely unknown,
but various hypotheses have been put forward includ-
ing, but not limited to, autonomic dysfunction resulting
in catecholamine-induced myocardial injury. In 70% of
patients there is a triggering factor (psychosocial or physical)
identiﬁed. Additional hypotheses include catecholamine-
induced myocardial stunning, ischemia-mediated stunning
due to coronary vasospasm, and myocarditis [7–10]. The
predominanceinmiddle-agedfemaleshasalsoraisedapossi-
bility of hormonal inﬂuence, especially estrogen withdrawal
in this age group. A case report of a patient with TC and
type 1 CD36 disorder has been described, leading to a
suspicion that perhaps there could be a link with abnormal
fatty acid metabolism [11].
The most supported hypothesis is the catecholamine-
induced myocardial stunning, as evidenced by the elevated
levels of catecholamine prevalent in patients presenting
with TC. Endomyocardial biopsies done in symptomatic
patients have shown features of catecholamine toxicity [8].
In this hypothesis, a stressor triggers a catecholamine surge
in a susceptible individual, leading to impaired myocardial
perfusion, myocyte injury, and rarely left ventricular outﬂow
tract obstruction. The combined molecular eﬀect of these
insultsonmetabolicpathwaysgivesrisetoTC[4,7–10].This
hypothesis is still insuﬃcient to explain issues such as female
predominance,agegroupaﬀected,lowrecurrencerisk,orthe
failure to reproduce the disease in animal models.
Recently Burgdorf et al. [5] observed a possible link
between malignancies and occurrence of TC. In a ret-
rospective cohort study of 50 TC patients, 18% had a
previous history of malignancy, with another 14% devel-
oping malignancies over a mean 2.8-year follow-up. Since
the occurrence of malignancies was higher in this cohort
than the general population, it led them to speculate that
TC might be a paraneoplastic phenomenon. Cancers are
thought to cause catecholamine-induced myocardial injury
through either increasing cardiac sympathetic activity or
distorting cardiac adrenoceptor sensitivity. The distortion of
adrenoceptor sensitivity might be caused by manipulation of
the protein synthesis process intracellularly or extracellularly
throughpossiblyadrenoceptorautoantibodies.Burgdorfalso
speculated that cancer probably lowers the psychic threshold
to stress, hence resulting in elevated levels of stress hormones
which act on aggravated adrenoceptors [5]. In a larger
retrospective study of 100 patients, Elesber et al. [6]f o u n d
the mortality due to malignancies to be <1% over a mean
4.4-year follow-up period.
What makes our case more interesting is the close rela-
tionship known to exist between adrenoceptor dysregulation
and proliferation of adenocarcinoma cells, especially breast
and colon [12, 13]. It is possible that during the process of
inducing self-proliferation, the cancer cells cause adrenocep-
tor dysregulation aﬀecting the cardiac cells, resulting in TC.
Unfortunately, neither Burgdorf [5]n o rE l e s be r[ 6]p r o vi d ed
the histopathological characteristics of the cancers among
their subjects. Even then, this hypothesis might not explain
why TC does not occur in all people with adenocarcinoma,
which implies that there are other factors at play.
Most patients present with symptoms of acute coronary
syndrome, chest pain, shortness of breath, cardiac enzyme
elevation (mild), ST segment elevation, T wave inversion,
or QT prolongation. Rare presenting symptoms include syn-
cope, cardiac arrest, cardiogenic shock, or congestive failure.
Patients in the intensive care unit might have pulmonary
edema. Unique to this entity is preceding emotional or
physical stress, although this is absent in about 30% of cases.
Echocardiography reveals regional wall motion abnor-
malities. Deﬁnitive diagnosis is made on cardiac catheteri-
zation, which reveals two classical features: normal coronary
arteries and aneurismal dilatation or ballooning of apical
segment of the left ventricle (LV), appearing like a Japanese
octopus trap on ventriculography. Other variants described
are apical sparing or inverted tako-tsubo.
Various diagnostic criteria exist, none of which has
been adopted universally. The common criteria used are the
proposed Mayo Clinic criteria, initially proposed by Bybee
et al. [7] but recently revised by Prasad et al. [4] into
the modiﬁed Mayo Clinic criteria. These criteria emphasize
four characteristics a patient must have in order to be
diagnosed with TC. These are transient hypokinesis or
apical akinesis not limited to one vascular distribution,
absence of signiﬁcant obstructive coronary lesion, new ECG
abnormalities with modest rise in cardiac troponin, andCase Reports in Medicine 3
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Figure 1: Signiﬁcant ST segment elevation in precordial leads V1–V3 noted at the time of patient presentation.
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Figure 2: Left ventricular apical akinesia and ballooning visualized
during systole on echocardiography.
absence of myocarditis or pheochromocytoma. Our patient
met the modiﬁed Mayo Clinic criteria.
Managementissupportive.Sincebythetimeofdiagnosis
most patients are on treatment for acute coronary syndrome,
this is usually continued. The beneﬁt of beta-blockers is
unknown although theoretically, since they have an anti-
catecholamine eﬀect, they are given, especially those with
both alpha- and beta-receptor blockade, like carvedilol.
Diuretics are recommended for heart failure. Precautions
must be taken to avoid thrombolysis as it might cause
harm. Short-term anticoagulation can be given to patients
who present with atrial ﬁbrillation or thrombus formation
[14]. Aspirin and renin angiotensin system inhibitors are
not needed if the patient has no atherosclerosis or recovers
systolic function, respectively.
Complications include left ventricular free-wall rupture,
ventricular arrhythmias, mitral regurgitation, left ventric-
ular mural thrombus formation, dynamic intraventricular
obstruction, and death [7, 14–19]. In-hospital mortality
Figure 3: Anteroapical ballooning of left ventricle during systole as
seen on left ventriculogram.
from TC is estimated at 1% to 2%, with long-term survival
the same as a general age-matched population. Hence, prog-
nosis is good, with patients’ LV systolic function recovering
after four to six weeks, although it can sometimes take up to
a year. Recurrence is less than 10% [4, 6].
This case hence raises two other interesting clinical
issues. The ﬁrst issue concerns which level of the troponin
I elevation is clinically useful, and whether a degree of
elevation matters. In this patient the troponin I elevation
was not what we can refer to as modest, yet she did meet
the modiﬁed Mayo Clinic diagnostic criteria. This chal-
lenges the clinical emphasis placed on “modest” troponin
I elevation. The second issue is that the studies by Elesber
[6]a n dB u r g d o r f[ 5] are relatively small, and the mean
age of subjects was 60 to 70 years, an age group with a4 Case Reports in Medicine
higher risk of malignancies in the general population [20].
This means that the ﬁnding of both malignancy and TC
could be circumstantial. Nevertheless, from what we already
knowabouttherelationshipbetweenadenocarcinoma,stress
hormones, and adrenoceptor dysregulation, this hypothesis
is legitimate. Retrospectively, measurement of adrenoceptor
autoantibodies in our patient would have shed more light
on this hypothesis. However, this is not readily available
in laboratories, and evidence of a direct causal relationship
with Tako-Tsubo cardiomyopathy is still lacking. Further
exploration with more studies is required.
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